Disclosed herein are methods for the reduction of inter-patient variability of a drug, such as in one or more parameters including half-life (t
1/2
), maximum plasma concentration (C
max
), time at maximal plasma concentration (T
max
), area under the time-versus-concentration curve (AUC). Also provided are methods of reducing side effects associated with drugs.